Development and Validation of a Discriminating In Vitro Dissolution Method for a Poorly Soluble Drug, Olmesartan Medoxomil: Comparison Between Commercial Tablets
Gespeichert in:
Verfasser / Beitragende:
[Lisiane Bajerski, Rochele Rossi, Carolina Dias, Ana Bergold, Pedro Fröehlich]
Ort, Verlag, Jahr:
2010
Enthalten in:
AAPS PharmSciTech, 11/2(2010-06-01), 637-644
Format:
Artikel (online)
Online Zugang: